00

Renhe Pharmacy Co LtdSHE 000650 Stock Report

Last reporting period 30 Sep, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

1.102

Small

Exchange

XSHE - Shenzhen Stock Exchange

000650.SZ Stock Analysis

00

Neutral

Based on Eyestock quantitative analysis, 000650.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

96/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

24.9 %

Greatly undervalued

Market cap $B

1.102

Dividend yield

3.31 %

Shares outstanding

1 399.94 B

Renhe Pharmacy Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nanchang, Jiangxi and currently employs 7,055 full-time employees. The firm is mainly engaged in medical industrial manufacturing and medical merchandising. The Company’s main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The firm is also involved in the wholesaling and retailing of health-related products. The firm distributes its products mainly in domestic market.

View Section: Eyestock Rating